CellaVision AB (publ) (STO:CEVI)
Sweden flag Sweden · Delayed Price · Currency is SEK
157.80
0.00 (0.00%)
Aug 15, 2025, 5:29 PM CET

CellaVision AB Revenue

CellaVision AB had revenue of 191.33M SEK in the quarter ending June 30, 2025, with 1.88% growth. This brings the company's revenue in the last twelve months to 751.47M, up 3.45% year-over-year. In the year 2024, CellaVision AB had annual revenue of 723.22M with 6.78% growth.

Revenue (ttm)
751.47M
Revenue Growth
+3.45%
P/S Ratio
5.01
Revenue / Employee
3.28M
Employees
219
Market Cap
3.76B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024723.22M45.93M6.78%
Dec 31, 2023677.29M37.95M5.94%
Dec 31, 2022639.34M73.79M13.05%
Dec 31, 2021565.55M94.11M19.96%
Dec 31, 2020471.44M9.67M2.09%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Swedish Orphan Biovitrum AB 26.97B
Sectra AB 3.31B
Getinge AB 35.50B
Medicover AB 25.22B
Camurus AB 2.27B
Asker Healthcare Group AB 15.88B
BioArctic AB 1.52B
Bonesupport Holding AB 1.06B
Revenue Rankings